Polymerase chain reaction-restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample

Helicobacter

Volumn 10, Issue 3, 2005, Pages 205-213

  Booka, Mina ^a   Okuda, Masumi ^b   Shin, Kouichirou ^c   Miyashiro, Eikichi ^b   Hayashi, Hiroko ^a   Yamauchi, Koji ^c   Tamura, Yoshitaka ^c   Yoshikawa, Norishige ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b WAKAYAMA ROSAI HOSPITAL   (Japan)

^c MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

Children; Clarithromycin resistance; Helicobacter pylori; Stool

Indexed keywords

BACTERIAL DNA; CLARITHROMYCIN; OLIGONUCLEOTIDE; RESTRICTION ENDONUCLEASE; RNA 23S;

ACCURACY; ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIGEN DETECTION; ARTICLE; BACTERIAL GENE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA PURIFICATION; FECES ANALYSIS; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFANT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FECES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFANT; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SENSITIVITY AND SPECIFICITY;

HELICOBACTER PYLORI;

EID: 20044371639     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00312.x     Document Type: Article

References (39)

1. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-9.
2. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, Malaty HM. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
3. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Eng J Med 1991;325:1132-6.
4. Vaira D, Holton J, Dowsett J, Oderda G, Barbara L. Helicobacter pylori: its role in gastric disease. Dig Dis 1990;8:322-36.
5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Eng J Med 2001;345:784-9.
6. Choe YH, Kwon YS, Jung MK, Kang SK, Hwang TS, Hong YC. Helicobacter pylori-associated iron-deficiency anemia in adolescent female athletes. J Pediatr 2001;139:100-4.
7. Konno M, Muraoka S, Takahashi M, Inami T. Iron-deficiency anemia associated with Helicobacter pylori gastritis. J Pediatr Gastroenterol Nutr 2000;31:52-6.
8. Emilina G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001;97:812-4.
9. Jones N, Sherman P. Helicobacter pylori infection in children. Curr Opin Pediatr 1998;10:19-23.
10. Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study. Helicobacter 1996;1:138-44.
11. Kato S, Ritsuno H, Ohnuma K, Iinuma K, Sugiyama T, Asaka M. Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. Helicobacter 1998;3:278-82.
12. Asaka M, Satoh K, Sugano K, Sugiyama T, Takahashi S, Fukuda Y, Ota H, Murakami K, Kimura K, Shimoyama T. Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 2001;6:177-86.
13. Rubin G, Meineche-Schmidt V, Roberts A, de Wit N. The use of consensus to develop guidelines for the management of Helicobacter pylori infection in primary care. Fam Pract 2000;17:S21-6.
14. Chiba N. Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. Am J Gastroenterol 1996;91:2139-43.
15. Gold B, Colletti R, Abbott M, Czinn S, Elitsur Y, Hassall E, Macarthur C, Snyder PM. North American Society for Pediatric Gastroenterology and Nutrition. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000;31:490-7.
16. Adamek R, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin-influence on treatment outcome. Am J Gastroenterol 1998;93:386-9.
17. Kato S, Fujiyama S, Udagawa H, Shimizu T, Maisawa S, Ozawa K, Iinuma K. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol 2002;40:649-53.
18. Street ME, Caruana P, Caffarelli C, Magliani W, Manfredi M, Fornaroli F, de'Angelis GL. Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome. Arch Dis Child 2001;84:419-22.
19. Charles L, Segreti J. Choosing the right macrolide antibiotic. A guide to selection. Drugs 1997;53:349-57.
20. Perez Aldana L, Kato M, Nakagawa S, et al. The relationship between consumption of antimicrobial agents and prevalence of primary Helicobacter pylori resistance. Helicobacter 2002;7:306-9.
21. Crone J, Granditsch G, Huber W-D, Binder C, Innerhofer A, Amann G, Hirschl AM. 2003 Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000. J Pediatr Gastroenterol Nutr 2003;36:368-71.
22. Osato M. Antimicrobial susceptibility testing for Helicobacter pylori: sensitivity test results and their clinical relevance. Curr Pharm Des 2000;6:1545-55.
23. Maeda S, Yoshida H, Ogura K, Kanai F, Shiratori Y, Omata M. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 1998;43:317-21.
24. Van Doom L-J, Glupczynski Y, Kusters J, Megraud F, Midolo P, Maggi-Solca N, Queiroz DM, Nouhan N, Stet E, Quint WG. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001;45:1500-4.
25. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J, Flamm RK, Tanaka SK, Graham DY, Go MF. Mutations m 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40:477-80.
26. Versalovic J, Osato M, Spakovsky K, Dore M, Reddy R, Stone G, Shortridge D, Flamm RK, Tanaka SK, Graham DY. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 1997;40:283-6.
27. Menard A, Santos A, Megraud F, Oleastro M. PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother 2002;46:1156-7.
28. Kato S, Ozawa K, Okuda M, Fujisawa T, Kagimoto S, Konno M, Maisawa S, Iinuma K. Accuracy of the stool antigen test for the diagnosis of childhood Helicobacter pylori infection: a multicenter Japanese study. Am J Gastroenterol 2003;98:296-300.
29. Okuda M, Nakazawa T, Booka M, Miyashiro E, Yosikawa N. Evaluation of a urine antibody test for Helicobacter pylori in Japanese children. J Pediatr 2004;144:196-9.
30. Okuda M, Miyashiro E, Koike M, Okuda S, Minami K, Yoshikawa N. Breast-feeding prevents Helicobacter pylori infection in early childhood. Pediatr Int 2001;43:714-5.
31. Meyer JM, Silliman NP, Wang W, Siepman NY, Sugg JE, Morris D, Zhang J, Bhattacharyya H, King EC, Hopkins RJ. Risk factors for Helicobacter pylori resistance in the United States. The surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-99. Ann Intern Med 2002;136:13-24.
32. Cabrita J, Oleastro M, Matos R, Manhente A, Cabral J, Barros R, Lopes AI, Ramalho P, Neves BC, Guerreiro AS. Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-99). J Antimicrob Chemother 2000;46:1029-31.
33. Taneike I, Goshi S, Tamuta Y, Wakisaka-Saito N, Matsumori N, Yanase A, Shimizu T, Yamashiro Y, Toyoda S, Yamamoto T. Emergence of clarithromycin- resistant Helicobacter pylori (CRHP) with a high prevalence in children compared to their parents. Helicobacter 2002;7:297-305.
34. Breuer T, Graham D. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? Am J Gastroenterol 1999;94:725-9.
35. Kabir S. Detection of Helicobacter pylori in faeces by culture, PCR and enzyme immunoassay. J Med Microbiol 2001;50:1021-9.
36. Makristathis A, Pasching E, Schutze K, Wimmer M, Rotter M, Hirschl A. Detection of Helicobacter pylori in stool specimens by PCR and antigen enzyme immunoassay. J Clin Microbiol 1998;36:2772-4.
37. Fontana C, Favaro M, Pietroiusti P, Pistoia E, Galante A, Favalli C. Detection of clarithromycin-resistant Helicobacter pylori in stool samples. J Clin Microbiol 2003;41:3636-40.
38. Monteiro J, Bonnemaison D, Vekris A, Petry KG, Bonnet J, Vidal R, Cabrita J, Mègraud F. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol 1997;35:995-8.
39. Schabereiter-Gurtner C, Hirschl AM, Dragosics B, Hufnagl P, Puz S, Kovch Z, Rotter M, Makristathis A. Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J Clin Microbiol 2004;42:4512-8.